Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gevers

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
The Netherlands Journal of Medicine|June 22, 2016
Full-dose sofosbuvir and daclatasvir for chronic hepatitis C infection in haemodialysis patientsT J G Gevers, D Burger, E Schipper-Reintjes, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 20, 2018
Regression of hepatocellular adenoma after bariatric surgery in severe obese patientsTom J G Gevers, B W Marcel Spanier, Peter B Veendrick, et al.
The Netherlands Journal of Medicine|June 8, 2011
Treatment extension benefits HCV genotype 1 patients without rapid virological response: a systematic reviewT J G Gevers, S Slavenburg, M G H van Oijen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 4, 2020
Discontinuation rate of azathioprineRomée J A L M Snijders, Simon Pape, Tom J G Gevers, et al.
The Netherlands Journal of Medicine|October 8, 2011
Hepatic and renal manifestations in autosomal dominant polycystic kidney disease: a dichotomy of two ends of a spectrumJ J M van Gulick, T J G Gevers, L van Keimpema, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2011
Low prevalence of cardiac valve abnormalities in patients with autosomal dominant polycystic liver diseaseTom J G Gevers, Daan B de Koning, Arie P van Dijk, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 21, 2015
Alkaline phosphatase predicts response in polycystic liver disease during somatostatin analogue therapy: a pooled analysisTom J G Gevers, Frederik Nevens, Vicente E Torres, et al.
Trials|April 16, 2015
Aspiration sclerotherapy combined with pasireotide to improve reduction of large symptomatic hepatic cysts (SCLEROCYST): study protocol for a randomized controlled trialTitus F M Wijnands, Tom J G Gevers, Leo J Schultze Kool, et al.
Expert Opinion on Therapeutic Targets|April 7, 2020
New insights into targeting hepatic cystogenesis in autosomal dominant polycystic liver and kidney diseaseThijs R M Barten, Lucas H P Bernts, Joost P H Drenth, et al.
Journal of Clinical Gastroenterology|August 23, 2022
Treatment of Polycystic Liver Disease: Impact on Patient-reported Symptom Severity and Health-related Quality of LifeRenée Duijzer, Thijs R M Barten, Christian B Staring, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
The Netherlands Journal of Medicine|June 22, 2016
Full-dose sofosbuvir and daclatasvir for chronic hepatitis C infection in haemodialysis patientsT J G Gevers, D Burger, E Schipper-Reintjes, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 20, 2018
Regression of hepatocellular adenoma after bariatric surgery in severe obese patientsTom J G Gevers, B W Marcel Spanier, Peter B Veendrick, et al.
The Netherlands Journal of Medicine|June 8, 2011
Treatment extension benefits HCV genotype 1 patients without rapid virological response: a systematic reviewT J G Gevers, S Slavenburg, M G H van Oijen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 4, 2020
Discontinuation rate of azathioprineRomée J A L M Snijders, Simon Pape, Tom J G Gevers, et al.
The Netherlands Journal of Medicine|October 8, 2011
Hepatic and renal manifestations in autosomal dominant polycystic kidney disease: a dichotomy of two ends of a spectrumJ J M van Gulick, T J G Gevers, L van Keimpema, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2011
Low prevalence of cardiac valve abnormalities in patients with autosomal dominant polycystic liver diseaseTom J G Gevers, Daan B de Koning, Arie P van Dijk, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 21, 2015
Alkaline phosphatase predicts response in polycystic liver disease during somatostatin analogue therapy: a pooled analysisTom J G Gevers, Frederik Nevens, Vicente E Torres, et al.
Trials|April 16, 2015
Aspiration sclerotherapy combined with pasireotide to improve reduction of large symptomatic hepatic cysts (SCLEROCYST): study protocol for a randomized controlled trialTitus F M Wijnands, Tom J G Gevers, Leo J Schultze Kool, et al.
Expert Opinion on Therapeutic Targets|April 7, 2020
New insights into targeting hepatic cystogenesis in autosomal dominant polycystic liver and kidney diseaseThijs R M Barten, Lucas H P Bernts, Joost P H Drenth, et al.
Journal of Clinical Gastroenterology|August 23, 2022
Treatment of Polycystic Liver Disease: Impact on Patient-reported Symptom Severity and Health-related Quality of LifeRenée Duijzer, Thijs R M Barten, Christian B Staring, et al.
Pageof 10